StreetInsider.com News Articles

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Mon, 01 Jun 2026 08:00:00 -0400

TEL AVIV, Israel, June 01, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that it will host a virtual key opinion leader (“KOL”) event on Wednesday, June 10, 2026 at 8:00 AM ET featuring Michael S. Blaiss, MD (Medical College of Georgia, Good Samaritan Health Center of Gwinnett) and Joel Brooks, DO, MPH (Columbia University Vagelos College of Physicians and Surgeons, New York-Presbyterian Morgan Stanley Children’s Hospital), who will join members of the Company’s management to discuss

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Mon, 01 Jun 2026 08:00:00 -0400

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Mon, 01 Jun 2026 08:00:00 -0400

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Mon, 01 Jun 2026 08:00:00 -0400

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Mon, 01 Jun 2026 08:00:00 -0400

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Mon, 01 Jun 2026 08:00:00 -0400

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Mon, 01 Jun 2026 08:00:00 -0400

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Mon, 01 Jun 2026 08:00:00 -0400

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Mon, 01 Jun 2026 08:00:00 -0400

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Mon, 01 Jun 2026 08:00:00 -0400

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Mon, 01 Jun 2026 08:00:00 -0400

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Mon, 01 Jun 2026 08:00:00 -0400

Form S-8 Nasus Pharma Ltd

Tue, 26 May 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260526/26551320.html

Form S-8 Nasus Pharma Ltd

Tue, 26 May 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260526/26551320.html

Form SCHEDULE 13G Nasus Pharma Ltd Filed by: BALYASNY ASSET MANAGEMENT L.P.

Fri, 15 May 2026 06:22:00 -0400

si-local-file:///var/storage/secattach/20260515/26498856.html

Form SCHEDULE 13G Nasus Pharma Ltd Filed by: BALYASNY ASSET MANAGEMENT L.P.

Fri, 15 May 2026 06:22:00 -0400

si-local-file:///var/storage/secattach/20260515/26498856.html

Nasus Pharma to Participate in Upcoming Investor Conferences

Fri, 01 May 2026 09:13:59 -0400

TEL AVIV, Israel, May 01, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that Company management will participate in upcoming investor conferences.

Market Movers Investor Summit
May 5, 2026, New York, NY
Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

D. Boral Capital Global Conference
May 7, 2026, New York, NY
Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

Interested investors should contact their respective representatives at the

Nasus Pharma to Participate in Upcoming Investor Conferences

Fri, 01 May 2026 09:13:59 -0400

Market Movers Investor Summit
May 5, 2026, New York, NY
Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

D. Boral Capital Global Conference
May 7, 2026, New York, NY
Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

Interested investors should contact their respective representatives at the

Nasus Pharma to Participate in Upcoming Investor Conferences

Fri, 01 May 2026 09:13:00 -0400

Market Movers Investor Summit

May 5, 2026, New York, NY

Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

D. Boral Capital Global Conference

May 7, 2026, New York, NY

Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

Interested investors should contact their respective representatives at the sponsoring institutions to request

Nasus Pharma to Participate in Upcoming Investor Conferences

Fri, 01 May 2026 09:13:00 -0400

Market Movers Investor Summit

May 5, 2026, New York, NY

Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

D. Boral Capital Global Conference

May 7, 2026, New York, NY

Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

Interested investors should contact their respective representatives at the sponsoring institutions to request

Nasus Pharma to Participate in Upcoming Investor Conferences

Fri, 01 May 2026 09:13:00 -0400

Market Movers Investor Summit

May 5, 2026, New York, NY

Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

D. Boral Capital Global Conference

May 7, 2026, New York, NY

Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

Interested investors should contact their respective representatives at the sponsoring institutions to request

Nasus Pharma to Participate in Upcoming Investor Conferences

Fri, 01 May 2026 09:13:00 -0400

Market Movers Investor Summit

May 5, 2026, New York, NY

Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

D. Boral Capital Global Conference

May 7, 2026, New York, NY

Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

Interested investors should contact their respective representatives at the sponsoring institutions to request

Nasus Pharma to Participate in Upcoming Investor Conferences

Fri, 01 May 2026 09:13:00 -0400

Market Movers Investor Summit

May 5, 2026, New York, NY

Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

D. Boral Capital Global Conference

May 7, 2026, New York, NY

Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

Interested investors should contact their respective representatives at the sponsoring institutions to request

Nasus Pharma to Participate in Upcoming Investor Conferences

Fri, 01 May 2026 09:13:00 -0400

Market Movers Investor Summit

May 5, 2026, New York, NY

Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

D. Boral Capital Global Conference

May 7, 2026, New York, NY

Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

Interested investors should contact their respective representatives at the sponsoring institutions to request

Nasus Pharma to Participate in Upcoming Investor Conferences

Fri, 01 May 2026 09:13:00 -0400

Market Movers Investor Summit

May 5, 2026, New York, NY

Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

D. Boral Capital Global Conference

May 7, 2026, New York, NY

Chief Financial Officer Eyal Rubin will participate in 1x1 meetings.

Interested investors should contact their respective representatives at the sponsoring institutions to request